196 related articles for article (PubMed ID: 29190549)
1. Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight.
Baila-Rueda L; Cenarro A; Lamiquiz-Moneo I; Perez-Calahorra S; Bea AM; Marco-Benedí V; Jarauta E; Mateo-Gallego R; Civeira F
J Nutr Biochem; 2018 Mar; 53():48-57. PubMed ID: 29190549
[TBL] [Abstract][Full Text] [Related]
2. Bile acid synthesis precursors in subjects with genetic hypercholesterolemia negative for LDLR/APOB/PCSK9/APOE mutations. Association with lipids and carotid atherosclerosis.
Baila-Rueda L; Cenarro A; Lamiquiz-Moneo I; Mateo-Gallego R; Bea AM; Perez-Calahorra S; Marco-Benedi V; Civeira F
J Steroid Biochem Mol Biol; 2017 May; 169():226-233. PubMed ID: 27769814
[TBL] [Abstract][Full Text] [Related]
3. Increased intestinal cholesterol absorption in autosomal dominant hypercholesterolemia and no mutations in the low-density lipoprotein receptor or apolipoprotein B genes.
García-Otín AL; Cofán M; Junyent M; Recalde D; Cenarro A; Pocoví M; Ros E; Civeira F
J Clin Endocrinol Metab; 2007 Sep; 92(9):3667-73. PubMed ID: 17566095
[TBL] [Abstract][Full Text] [Related]
4. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
Brouwers MC; Konrad RJ; van Himbergen TM; Isaacs A; Otokozawa S; Troutt JS; Schaefer EJ; van Greevenbroek MM; Stalenhoef AF; de Graaf J
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1115-21. PubMed ID: 23333725
[TBL] [Abstract][Full Text] [Related]
5. Bile acid synthesis precursors in familial combined hyperlipidemia: the oxysterols 24S-hydroxycholesterol and 27-hydroxycholesterol.
Baila-Rueda L; Mateo-Gallego R; Jarauta E; de Castro-Orós I; Bea AM; Cenarro A; Civeira F
Biochem Biophys Res Commun; 2014 Apr; 446(3):731-5. PubMed ID: 24406166
[TBL] [Abstract][Full Text] [Related]
6. ABCG5/G8 gene is associated with hypercholesterolemias without mutation in candidate genes and noncholesterol sterols.
Lamiquiz-Moneo I; Baila-Rueda L; Bea AM; Mateo-Gallego R; Pérez-Calahorra S; Marco-Benedí V; Martín-Navarro A; Ros E; Cofán M; Rodríguez-Rey JC; Pocovi M; Cenarro A; Civeira F
J Clin Lipidol; 2017; 11(6):1432-1440.e4. PubMed ID: 29066094
[TBL] [Abstract][Full Text] [Related]
7. Non-cholesterol sterols in different forms of primary hyperlipemias.
Lupattelli G; Pirro M; Siepi D; Mannarino MR; Roscini AR; Vaudo G; Pasqualini L; Schillaci G; Mannarino E
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):231-6. PubMed ID: 20708389
[TBL] [Abstract][Full Text] [Related]
8. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
[TBL] [Abstract][Full Text] [Related]
9. Serum lipid responses to weight loss differ between overweight adults with familial hypercholesterolemia and those with familial combined hyperlipidemia.
Mateo-Gallego R; Perez-Calahorra S; Cofán M; Baila-Rueda L; Cenarro A; Ros E; Puzo J; Civeira F
J Nutr; 2014 Aug; 144(8):1219-26. PubMed ID: 24899155
[TBL] [Abstract][Full Text] [Related]
10. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein B is associated with metabolic syndrome in Chinese families with familial combined hyperlipidemia, familial hypertriglyceridemia and familial hypercholesterolemia.
Pei WD; Sun YH; Lu B; Liu Q; Zhang CY; Zhang J; Jia YH; Lu ZL; Hui RT; Liu LS; Yang YJ
Int J Cardiol; 2007 Mar; 116(2):194-200. PubMed ID: 16828905
[TBL] [Abstract][Full Text] [Related]
12. Cosegregation of serum cholesterol with cholesterol intestinal absorption markers in families with primary hypercholesterolemia without mutations in LDLR, APOB, PCSK9 and APOE genes.
Baila-Rueda L; Pérez-Ruiz MR; Jarauta E; Tejedor MT; Mateo-Gallego R; Lamiquiz-Moneo I; de Castro-Orós I; Cenarro A; Civeira F
Atherosclerosis; 2016 Mar; 246():202-7. PubMed ID: 26802983
[TBL] [Abstract][Full Text] [Related]
13. Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia.
Noto D; Cefalù AB; Barraco G; Martino E; Fayer F; Minà M; Montali A; Arca M; Averna M; Martino F
Pediatr Res; 2010 Feb; 67(2):200-4. PubMed ID: 20091938
[TBL] [Abstract][Full Text] [Related]
14. [Apolipoprotein B is associated with metabolic syndrome in Chinese pedigrees with familial hyperlipidemia].
Pei WD; Sun YH; Rou WJ; Zu Q; Li Y; Zhang CY; Dai J; Jia YH; Lu ZL; Wu XG; Liu LS; Hui RT
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):313-7. PubMed ID: 15854507
[TBL] [Abstract][Full Text] [Related]
15. Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
Minicocci I; Prisco C; Montali A; Di Costanzo A; Ceci F; Pigna G; Arca M
Atherosclerosis; 2015 Oct; 242(2):618-24. PubMed ID: 26342331
[TBL] [Abstract][Full Text] [Related]
16. Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies.
Taghizadeh E; Esfehani RJ; Sahebkar A; Parizadeh SM; Rostami D; Mirinezhad M; Poursheikhani A; Mobarhan MG; Pasdar A
IUBMB Life; 2019 Sep; 71(9):1221-1229. PubMed ID: 31271707
[TBL] [Abstract][Full Text] [Related]
17. [The hypercholesterolemias in pregnancy: their etiology and diagnostic significance considerations].
Hyánek J; Pehal F; Dubská L; Miková J; Gombíková L; Kubů S; Haláčková P; Feyereisl J; Táborský L
Ceska Gynekol; 2017; 82(6):455-461. PubMed ID: 29302979
[TBL] [Abstract][Full Text] [Related]
18. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.
Vikulova DN; Trinder M; Mancini GBJ; Pimstone SN; Brunham LR
Can J Cardiol; 2021 Nov; 37(11):1733-1742. PubMed ID: 34455025
[TBL] [Abstract][Full Text] [Related]
19. Gas Chromatography and Flame-Ionization Detection of Non-Cholesterol Sterols as Indicators of Cholesterol Absorption and Synthesis in 158 Chinese Individuals with Normolipidemia, Hyperlipidemia, and Familial Hypercholesterolemia.
Li ZZ; Wang QH; Liu Y; Wang L; Yu ZQ; Huang Q; Zhang J
Med Sci Monit; 2022 Feb; 28():e934471. PubMed ID: 35152260
[TBL] [Abstract][Full Text] [Related]
20. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
